Enanta Pharmaceuticals (ENTA) Earnings Date & Reports

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ENTA is expected to report earnings to rise 1.87% to -45 cents per share on August 10

Enanta Pharmaceuticals ENTA Stock Earnings Reports

Q2'26

Est.

$-0.46

Q1'26

Beat

by $0.12

Q4'25

Beat

by $0.39

Q3'25

Beat

by $0.14

Q2'25

Missed

by $0.01

The last earnings report on May 11 showed earnings per share of -44 cents, beating the estimate of -56 cents. With 158.11K shares outstanding, the current market capitalization sits at 322.48M.

View a ticker or compare two or three

Compare

ENTA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ENTA